tiprankstipranks
pc:pep5t

Peptilogics

Peptilogics is a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections. The company's lead candidate, zaloganan (PLG0206), is an investigational treatment for prosthetic joint infections currently in clinical development.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$78M
Total Amount Raised$78M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$78M
Latest Funding Amount$78M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 16, 2025
Series B
$78.00M

Investors

Investor Name
Funding Round

Related News and Analysis